We assessed whether genetic deletion of SLC7A5 in T cells affect GVT response using a BALB/c compatible murine lung carcinoma cell line, KLN-205, injected in the flank of recipient mice (Fig. EV5). This evidence concerns the gene SLC7A5 and lung carcinoma.